Clinical Trials Directory

Trials / Unknown

UnknownNCT03149406

Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest

Status
Unknown
Phase
Study type
Observational
Enrollment
245 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Carotid stenosis of atherosclerotic origin may be responsible for stroke, which is one of the most important causes of morbidity and mortality in the Western world

Detailed description

Carotid stenosis of atherosclerotic origin may be responsible for stroke, which is one of the most important causes of morbidity and mortality in the Western world. The constitution of the atheroma plaque is linked to the deregulation of several biological phenomena, including angiogenesis, adipogenesis, inflammatory response, lipid metabolism and oxidative stress. In addition to its anatomical and physiological characteristics, the notion of plate stability is of paramount importance for clinical implications. This stability depends largely on the biological composition of the plate. A vulnerable or unstable plaque often has a large lipid body consisting of foam cells (macrophages laden with oxidized LDL) with a thin fibrous screed consisting of smooth muscle cells (CML), collagen fibers and extracellular matrix. This plaque is also made up of numerous inflammatory cells including macrophages, rich vascularization and intraplate hemorrhage. Although the cell composition of the unstable plate is still relatively established, its molecular analysis remains little known. The benefit of carotid surgery in asymptomatic patients with stenosis greater than 70% is increasingly controversial given the moderate risk of spontaneous stroke under optimal medical treatment. This annual average risk is less than 5%. Thus, the discovery of an original and innovative biomarker, predictive of plate rupture, would define the patients most at risk, who benefit most from this surgery.

Conditions

Interventions

TypeNameDescription
OTHERComparing the expression of miRNAsby PCR, in symptomatic and asymptomatic carotid plaques.

Timeline

Start date
2012-12-26
Primary completion
2020-12-26
Completion
2020-12-26
First posted
2017-05-11
Last updated
2018-08-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03149406. Inclusion in this directory is not an endorsement.